The final session of EURETINA 2026 looked back over the week. In the first of two parts, we revisit the highlights from AMD, diabetes, tumours, surgery, clinical trials, vasculitis and inherited retinal disease.
Congress Highlights, Part 1: Gene Therapy, a Retinal Implant and Systemic Clues Read More »
In the second part of our look back at the closing session, we cover myopia surgery, lifestyle and genetics in dry AMD, global AI models, robotics, diabetic retinopathy screening and the limits of retinal age.
Congress Highlights, Part 2: Myopia, Lifestyle and the Frontier of AI Read More »
View photos from the delegate party on Saturday evening.
Photo gallery: Delegate Party Read More »
Five talks in a Sunday morning session showed how thinking about diabetic eye disease is shifting, from protecting the whole retinal neurovascular unit to using AI for screening, and from a single view of macular oedema to four distinct phenotypes.
Rethinking Diabetic Retinal Disease: From Neurovascular Targets to AI-Guided Care Read More »
The congress is only one part of what EURETINA offers. Between meetings, free educational content and a range of grants, programmes and communities keep the retina community connected.
More Than a Congress: Free Resources and Career Support from EURETINA Read More »
